107 related articles for article (PubMed ID: 16808956)
41. Autophagy is involved in T cell death after binding of HIV-1 envelope proteins to CXCR4.
Espert L; Denizot M; Grimaldi M; Robert-Hebmann V; Gay B; Varbanov M; Codogno P; Biard-Piechaczyk M
J Clin Invest; 2006 Aug; 116(8):2161-72. PubMed ID: 16886061
[TBL] [Abstract][Full Text] [Related]
42. Differential expression of human immunodeficiency virus coreceptors, by CEM, CEMVBL, and CEM E1000 cells.
Owen A; Chandler B; Ford J; Khoo S; Back D
J Infect Dis; 2003 Mar; 187(5):874-5; author reply 875-6. PubMed ID: 12599066
[No Abstract] [Full Text] [Related]
43. Induction of 15-lipoxygenase-1 impairs expression of HIV-1 receptors CD4 and CXCR4 in monocytic cells.
Chaitidis P; Kuhn H
FEBS Lett; 2005 Jul; 579(17):3691-4. PubMed ID: 15967444
[TBL] [Abstract][Full Text] [Related]
44. A zinc clasp structure tethers Lck to T cell coreceptors CD4 and CD8.
Kim PW; Sun ZY; Blacklow SC; Wagner G; Eck MJ
Science; 2003 Sep; 301(5640):1725-8. PubMed ID: 14500983
[TBL] [Abstract][Full Text] [Related]
45. Glycosphingolipids promote entry of a broad range of human immunodeficiency virus type 1 isolates into cell lines expressing CD4, CXCR4, and/or CCR5.
Hug P; Lin HM; Korte T; Xiao X; Dimitrov DS; Wang JM; Puri A; Blumenthal R
J Virol; 2000 Jul; 74(14):6377-85. PubMed ID: 10864648
[TBL] [Abstract][Full Text] [Related]
46. Discovery of 4-benzoyl-1-[(4-methoxy-1H- pyrrolo[2,3-b]pyridin-3-yl)oxoacetyl]-2- (R)-methylpiperazine (BMS-378806): a novel HIV-1 attachment inhibitor that interferes with CD4-gp120 interactions.
Wang T; Zhang Z; Wallace OB; Deshpande M; Fang H; Yang Z; Zadjura LM; Tweedie DL; Huang S; Zhao F; Ranadive S; Robinson BS; Gong YF; Ricarrdi K; Spicer TP; Deminie C; Rose R; Wang HG; Blair WS; Shi PY; Lin PF; Colonno RJ; Meanwell NA
J Med Chem; 2003 Sep; 46(20):4236-9. PubMed ID: 13678401
[TBL] [Abstract][Full Text] [Related]
47. Mobility of the human immunodeficiency virus (HIV) receptor CD4 and coreceptor CCR5 in living cells: implications for HIV fusion and entry events.
Steffens CM; Hope TJ
J Virol; 2004 Sep; 78(17):9573-8. PubMed ID: 15308751
[TBL] [Abstract][Full Text] [Related]
48. Specific transduction of HIV-1 envelope expressing cells by retroviral vectors pseudotyped with hybrid CD4/CXCR4 receptors.
Bittner A; Mitnacht-Kraus R; Schnierle BS
J Virol Methods; 2002 Jun; 104(1):83-92. PubMed ID: 12020795
[TBL] [Abstract][Full Text] [Related]
49. The HIV-1 co-receptor CCR5 binds to alpha-catenin, a component of the cellular cytoskeleton.
Schweneker M; Bachmann AS; Moelling K
Biochem Biophys Res Commun; 2004 Dec; 325(3):751-7. PubMed ID: 15541354
[TBL] [Abstract][Full Text] [Related]
50. Blocking the docking of HIV-1.
McKnight A; Weiss RA
Proc Natl Acad Sci U S A; 2003 Sep; 100(19):10581-2. PubMed ID: 12963807
[No Abstract] [Full Text] [Related]
51. HIV-1 membrane fusion: targets of opportunity.
Doms RW; Moore JP
J Cell Biol; 2000 Oct; 151(2):F9-14. PubMed ID: 11038194
[No Abstract] [Full Text] [Related]
52. Protein minimization of the gp120 binding region of human CD4.
Sharma D; Balamurali MM; Chakraborty K; Kumaran S; Jeganathan S; Rashid U; Ingallinella P; Varadarajan R
Biochemistry; 2005 Dec; 44(49):16192-202. PubMed ID: 16331979
[TBL] [Abstract][Full Text] [Related]
53. A dynamic three-step mechanism drives the HIV-1 pre-fusion reaction.
Iliopoulou M; Nolan R; Alvarez L; Watanabe Y; Coomer CA; Jakobsdottir GM; Bowden TA; Padilla-Parra S
Nat Struct Mol Biol; 2018 Sep; 25(9):814-822. PubMed ID: 30150645
[TBL] [Abstract][Full Text] [Related]
54. Insights into the mechanism of inhibition of CXCR4: identification of Piperidinylethanamine analogs as anti-HIV-1 inhibitors.
Das D; Maeda K; Hayashi Y; Gavande N; Desai DV; Chang SB; Ghosh AK; Mitsuya H
Antimicrob Agents Chemother; 2015 Apr; 59(4):1895-904. PubMed ID: 25583709
[TBL] [Abstract][Full Text] [Related]
55. Structural mapping of CD134 residues critical for interaction with feline immunodeficiency virus.
de Parseval A; Chatterji U; Morris G; Sun P; Olson AJ; Elder JH
Nat Struct Mol Biol; 2005 Jan; 12(1):60-6. PubMed ID: 15592478
[TBL] [Abstract][Full Text] [Related]
56. Efficient trapping of HIV-1 envelope protein by hetero-oligomerization with an N-helix chimera.
Ou W; Silver J
Retrovirology; 2005 Aug; 2():51. PubMed ID: 16092970
[TBL] [Abstract][Full Text] [Related]
57. Rescue of HIV-1 receptor function through cooperation between different forms of the CCR5 chemokine receptor.
Chelli M; Alizon M
J Biol Chem; 2002 Oct; 277(42):39388-96. PubMed ID: 12154092
[TBL] [Abstract][Full Text] [Related]
58. Influence of membrane fluidity on human immunodeficiency virus type 1 entry.
Harada S; Yusa K; Monde K; Akaike T; Maeda Y
Biochem Biophys Res Commun; 2005 Apr; 329(2):480-6. PubMed ID: 15737612
[TBL] [Abstract][Full Text] [Related]
59. A CXCR4/CD4 pseudotype rhabdovirus that selectively infects HIV-1 envelope protein-expressing cells.
Mebatsion T; Finke S; Weiland F; Conzelmann KK
Cell; 1997 Sep; 90(5):841-7. PubMed ID: 9298896
[TBL] [Abstract][Full Text] [Related]
60. Membrane raft microdomains mediate lateral assemblies required for HIV-1 infection.
Mañes S; del Real G; Lacalle RA; Lucas P; Gómez-Moutón C; Sánchez-Palomino S; Delgado R; Alcamí J; Mira E; Martínez-A C
EMBO Rep; 2000 Aug; 1(2):190-6. PubMed ID: 11265761
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
